Group Telehealth Behavioral Cough Suppression Therapy

Recruiting Early Phase 1 Interventional Study
Refractory Chronic Cough
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of Montana · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patien…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * At least 18 years old * Predominantly dry cough for at least 8 weeks * Evaluated and treated by at least one physician for cough * Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results * Access to a computer or tablet that includes…
Contacts

Jane E Reynolds, PhD

406-243-2138

jane.reynolds@mso.umt.edu

CONTACT

Laurie J Slovarp, PhD

406-243-2107

laurie.slovarp@mso.umt.edu

CONTACT